Novel Therapeutic Strategies in Major Depression: Focus on RNAi and Ketamine

E-ISSN： 1873-4286|20|23|3848-3860

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.23, 2014-01, pp. : 3848-3860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patent strategies for therapeutic RNAi

By Highlander Steven L Wohlers Travis M

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 11, 2008-11 ,pp. : 1289-1298

Informa Healthcare

Access to resources Recommend Favorite

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

By Orlacchio Antonio Bernardi Giorgio Orlacchio Aldo Martino Sabata

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

Catecholaminergic Strategies for the Treatment of Major Depression

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 149-158

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Strategies for Dementia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 2, 2016-03 ,pp. : 141-241

Bentham Science Publishers

Access to resources Recommend Favorite

Augmentation Strategies to Improve Treatment of Major Depression

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 2, 2006-01 ,pp. : 135-152

Bentham Science Publishers

Access to resources Recommend Favorite